作者：
Mukherjee,S. [1]
;
Hurt,C.N. [2]
;
Bridgewater,J. [3]
;
Falk,S. [4]
;
Cummins,S. [5]
;
Wasan,H. [6]
;
Crosby,T. [7]
;
Jephcott,C. [8]
;
Roy,R. [9]
;
Radhakrishna,G. [10]
;
McDonald,A. [11]
;
Ray,R. [12]
;
Joseph,G. [13]
;
Staffurth,J. [14]
;
Abrams,R.A. ;
Griffiths,G. ;
Maughan,T.
作者单位：
UCL Cancer Institute, University College London, London, United Kingdom
[1]
Hammersmith Hospital, London, United Kingdom
[2]
Wales Cancer Trials Unit, Cardiff University, Cardiff, United Kingdom
[3]
Gray Institute for Radiation Oncology and Biology, University of Oxford, NIHR Oxford Biomedical
[4]
Wales Cancer Trials Unit, Cardiff University, Cardiff, United Kingdom, Cardiff NCRI RTTQA Centre
[5]
Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
[6]
St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, United Kingdom
[7]
St James's Institute of Oncology, St James's University Hospital, Leeds, United Kingdom
[8]
Institute of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom, Cardiff NCRI RTTQA
[9]
Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, United States
[10]
Velindre Cancer Centre, Velindre Hospital, Cardiff, United Kingdom
[11]
Bristol Haematology and Oncology Centre, Bristol, United Kingdom
[12]
Diana Princess of Wales Hospital, Grimsby, United Kingdom
[13]
Department of Oncology, Addenbrooke's Hospital, Cambridge, United Kingdom
[14]
发布时间
2013-11-20
换一批
换一批
